American Society for Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and American Society of Clinical Oncology (ASCO) have released a new, evidence-based clinical practice guideline on molecular marker testing for patients with colorectal carcinoma that identifies opportunities for improving patient outcomes.


This pivotal guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer. This guideline will aid in establishing standard molecular marker testing to help guide targeted therapy decisions, and advance personalized care for colorectal cancer patients.


Go here to access the paper.


Speaker: Antonia R. Sepulveda MD, PhD

Duration: 1.0 hr

Level of Instruction: Basic


Go here to watch the webinar and earn CME/CMLE (Just $5.00 USD for AMP Members)

Go here to watch the webinar and earn SAM Credit (Just $10.00 USD for AMP Member)


Note: This webinar is free for all until October 2017. After October, members of AMP can access this webinar at no cost. Join the AMP Family!

Course Information
Course Date:
March 31, 2017
Course Objectives
  • Discuss the recently published molecular testing guidelines for colorectal cancer.
  • Describe current laboratory practice guidelines for the use and performance of molecular testing in the evaluation of colorectal cancer.
  • Evaluate prognosis and prediction of response to therapies for the following markers: KRAS, NRAS, BRAF, PIK3CA, PTEN, DNA mismatch repair/microsatellite instability.
Molecular Biomarkers for the Evaluation of Colorectal Cancer
Speaker Information
Antonia R. Sepulveda MD, PhD  [ view bio ]
Individual topic purchase: Selected
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00